3 ms·
In theory, yes, but delivery of the CRISPR enzyme to all the infected nuclei is still an unsolved problem. Also, it doesn't cut its target every time it does ge
by 88e282102ae2e5b 9y ago
In theory, yes, but delivery of the CRISPR enzyme to all the infected nuclei is still an unsolved problem. Also, it doesn't cut its target every time it does get in - some of the protein is inactive (probably just broken/malformed/misfolded) - but increasing the dose to compensate leads to more instances where it cuts the wrong target.